Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Hikma Pharmaceuticals PLC (HIKl)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,455.27 -10.00    -0.41%
22/10 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 49,013
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 2,435.00 - 2,477.00
Type:  Equity
Market:  Euro Zone
ISIN:  GB00B0LCW083 
Hikma Pharma 2,455.27 -10.00 -0.41%
Period Ending: 2021
30/06
2020
31/12
2020
30/06
2019
31/12
Total Current Assets 1955 1922 1878 1848
Cash and Short Term Investments 346 347 436 465
Cash 243 - - -
Cash & Equivalents 2 323 413 442
Short Term Investments 101 24 23 23
Total Receivables, Net 780 734 671 749
Accounts Receivables - Trade, Net 693 662 560 637
Total Inventory 736 757 684 568
Prepaid Expenses 78 58 66 49
Other Current Assets, Total 15 26 21 17
Total Assets 4180 4135 3970 3930
Property/Plant/Equipment, Total - Net 1061 1068 970 962
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 286 289 280 282
Intangibles, Net 620 587 570 552
Long Term Investments 36 34 32 29
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 222 235 240 257
Other Assets, Total - - - -
Total Current Liabilities 960 1028 1070 1471
Accounts Payable 226 279 272 286
Payable/Accrued - 470 - 473
Accrued Expenses 145 175 141 173
Notes Payable/Short Term Debt 132 117 108 60
Current Port. of LT Debt/Capital Leases 49 51 30 518
Other Current liabilities, Total 408 406 519 434
Total Liabilities 1890 2000 2080 1813
Total Long Term Debt 751 764 789 107
Long Term Debt 676 692 730 48
Capital Lease Obligations 75 72 59 59
Deferred Income Tax 21 31 22 20
Minority Interest 13 13 10 12
Other Liabilities, Total 145 164 189 203
Total Equity 2290 2135 1890 2117
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 41 41 41 41
Additional Paid-In Capital 282 282 282 282
Retained Earnings (Accumulated Deficit) 2197 2011 1814 2030
Treasury Stock - Common - - - -1
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -230 -199 -247 -235
Total Liabilities & Shareholders' Equity 4180 4135 3970 3930
Total Common Shares Outstanding 231.43 230.46 230.41 242.32
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HIK Comments

Write your thoughts about Hikma Pharmaceuticals
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Adeel Khan
Adeel Khan Oct 09, 2020 16:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Touch 27 today
Adeel Khan
Adeel Khan Sep 12, 2020 14:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next results will be super. Wait for it to hit £32 before end of this year
Jonny Tr
Jonny Tr Jun 17, 2020 15:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Aim listed Dark Matter Ltd, has more potential
Adeel Khan
Adeel Khan May 11, 2020 17:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This will go up & up
Steve Oliphant
Steve Oliphant Dec 04, 2019 9:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not as stated here (March 11)
Steve Oliphant
Steve Oliphant Dec 04, 2019 9:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hikma will announce their results for the year ended 31 December 2019 on 27 February 2020
Geoff Laidlaw
Geoff Laidlaw Jun 27, 2018 11:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any hint of progress on Advair will send this stock much higher still !
Geoff Laidlaw
Geoff Laidlaw May 18, 2018 21:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Underpriced without the Advair approvals ' unfortunate about the 2019 target for Advair !!!
Geoff Laidlaw
Geoff Laidlaw May 08, 2018 11:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Almost got me money back !!!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email